Advertisement

Uveal Neural Tumors

  • Victoria M. L. Cohen
  • Bertil E. Damato
  • Arun D. SinghEmail author
Chapter

Abstract

Peripheral nerve sheath tumors of the uveal tract arise mainly in the sheath of peripheral nerves that are found in the uvea. The ciliary nerve is most often affected, and hence these tumors tend to be located anteriorly, in the ciliary body or peripheral choroid in the anatomic location of the long ciliary nerve. There are several systemic predisposing risk factors, which include schwannomatosis, neurofibromatosis 1 (NF1) and 2, and other rare genetic syndromes. The benign tumors can be subclassified as neurofibroma and schwannoma. The malignant nerve sheath tumors are more difficult to subclassify if they lose the histological characteristics of their benign counterparts. In this chapter, we discuss uveal neurofibroma and schwannoma.

Keywords

Uveal neurofibroma Ganglioneurofibroma Uveal schwannoma 

References

  1. 1.
    Shields JA, Sanborn GE, Kurz GH, et al. Benign peripheral nerve tumor of the choroid: a clinicopathologic correlation and review of the literature. Ophthalmology. 1981;88(12):1322–9.PubMedCrossRefGoogle Scholar
  2. 2.
    Burke JP, Leitch RJ, Talbot JF, et al. Choroidal neurofibromatosis with congenital iris ectropion and buphthalmos: relationship and significance. J Pediatr Ophthalmol Strabismus. 1991;28(5):265–7.PubMedGoogle Scholar
  3. 3.
    Woog JJ, Albert DM, Craft J, et al. Choroidal ganglioneuroma in neurofibromatosis. Graefes Arch Clin Exp Ophthalmol. 1983;220(1):25–31.PubMedCrossRefGoogle Scholar
  4. 4.
    Goyal S, Park A, Zeglam A, et al. Choroidal ganglioneuroma and orbital plexiform neurofibroma presenting as buphthalmos in an infant with neurofibromatosis type 1. Ophthal Plast Reconstr Surg. 2016 Jul-Aug;32(4):87–9.CrossRefGoogle Scholar
  5. 5.
    Ishijima K, Kase S, Noda M, et al. Intraocular neovascularization associated with choroidal ganglioneuroma in neurofibromatosis type 1. Eur J Ophthalmol. 2011;21:837–40.PubMedCrossRefGoogle Scholar
  6. 6.
    Shome D, Vemuganti GK, Honavar SG. Choroidal ganglioneuroma in a patient with neurofibromatosis type 1: a case report. Eye (Lond). 2006;20:1450–1.CrossRefGoogle Scholar
  7. 7.
    Yazici B, Ozgun G, Adim SB. Choroidal ganglioneuroma in a patient with orbitopalpebral neurofibromatosis. Ophthal Plast Reconstr Surg. 2014;30:e140–2.PubMedCrossRefGoogle Scholar
  8. 8.
    Ozgun G, Adim SB, Yazici B. Co-occurrence of choroidal pigmented ganglioneuroma and plexiform neurofibroma in a patient with neurofibromatosis 1. Kaohsiung J Med Sci. 2014;30:215–6.PubMedCrossRefGoogle Scholar
  9. 9.
    Mbaqwu M, Rahmani B, Srivastava A, et al. Unsuspected ganglioneuroma of the choroid diagnosed after enucleation. Ocul Oncol Pathol. 2015 Sep;2(1):48–50.CrossRefGoogle Scholar
  10. 10.
    Brownstein S, Little JM. Ocular neurofibromatosis. Ophthalmology. 1983;90(12):1595–9.PubMedCrossRefGoogle Scholar
  11. 11.
    Yasunari T, Shiraki K, Hattori H, et al. Frequency of choroidal abnormalities in neurofibromatosis type 1. Lancet. 2000;356(9234):988–92.PubMedCrossRefGoogle Scholar
  12. 12.
    Kumar SS. Multimodar imaging of choroidal nodules in neurofibromatosis type 1. Indian J Ophthalmol. 2018;66(4):586–8.PubMedPubMedCentralCrossRefGoogle Scholar
  13. 13.
    Lewis RA, Riccardi VM. Von Recklinghausen neurofibromatosis. Incidence of iris hamartomata. Ophthalmology. 1981;88(4):348–54.PubMedCrossRefGoogle Scholar
  14. 14.
    Nakakura S, Shiraki K, Yasunari T, et al. Quantification and anatomic distribution of choroidal abnormalities in patients with type I neurofibromatosis. Graefes Arch Clin Exp Ophthalmol. 2005 Oct;243(10):980–4.PubMedCrossRefGoogle Scholar
  15. 15.
    Wei WB, Jie Y, Mo J, et al. Clinical characteristics and treatment of neurofibroma of the choroid. Chin Med J. 2012;125(10):1832–5.PubMedGoogle Scholar
  16. 16.
    Smith PA, Damato BE, Ko MK, et al. Anterior uveal neurilemmoma–a rare neoplasm simulating malignant melanoma. Br J Ophthalmol. 1987;71(1):34–40.PubMedPubMedCentralCrossRefGoogle Scholar
  17. 17.
    Kurtkaya-Yapicier O, Scheithauer B, Woodruff JM. The pathobiologic spectrum of schwannomas. Histol Histopathol. 2003;18(3):925–34.PubMedGoogle Scholar
  18. 18.
    You JY, Finger PT, Iacob C, et al. Intraocular schwannoma. Surv Ophthalmol. 2013;58(1):77–85.PubMedCrossRefGoogle Scholar
  19. 19.
    Reith JD, Goldblum JR. Multiple cutaneous plexiform schwannomas. Report of a case and review of the literature with particular reference to the association with types 1 and 2 neurofibromatosis and schwannomatosis. Arch Pathol Lab Med. 1996;120(4):399–401.PubMedGoogle Scholar
  20. 20.
    Freedman SF, Elner VM, Donev I, et al. Intraocular neurilemmoma arising from the posterior ciliary nerve in neurofibromatosis. Pathologic findings. Ophthalmology. 1988;95(11):1559–64.PubMedCrossRefGoogle Scholar
  21. 21.
    MacCollin M, Willett C, Heinrich B, et al. Familial schwannomatosis: exclusion of the NF2 locus as the germline event. Neurology. 2003;60(12):1968–74.PubMedCrossRefGoogle Scholar
  22. 22.
    Antinheimo J, Sankila R, Carpen O, et al. Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas. Neurology. 2000;54(1):71–6.PubMedCrossRefGoogle Scholar
  23. 23.
    Carney JA. The Carney complex (myxomas, spotty pigmentation, endocrine overactivity, and schwannomas). Dermatol Clin. 1995;13(1):19–26.PubMedCrossRefGoogle Scholar
  24. 24.
    Venturini G, Moulin AP, Deprez M, et al. Clinicopathologic and molecular analysis of a choroidal pigmented schwannoma in the context of a PTEN hamartoma tumor syndrome. Ophthalmology. 2012;119(4):857–64.PubMedCrossRefGoogle Scholar
  25. 25.
    Fan JT, Campbell RJ, Robertson DM. A survey of intraocular schwannoma with a case report. Can J Ophthalmol. 1995;30(1):37–41.PubMedGoogle Scholar
  26. 26.
    Matsuo T, Notohara K. Choroidal schwannoma: immunohistochemical and electron-microscopic study. Ophthalmologica. 2000;214(2):156–60.PubMedCrossRefGoogle Scholar
  27. 27.
    Saavedra E, Singh AD, Sears JE, et al. Plexiform pigmented schwannoma of the uvea. Surv Ophthalmol. 2006;51(2):162–8.PubMedCrossRefGoogle Scholar
  28. 28.
    Lee SH, Hong JS, Choi JH, et al. Choroidal schwannoma. Acta Ophthalmol Scand. 2005;83(6):754–6.PubMedCrossRefGoogle Scholar
  29. 29.
    Shields JA, Font RL, Eagle RC Jr, et al. Melanotic schwannoma of the choroid. Immunohistochemistry and electron microscopic observations. Ophthalmology. 1994;101(5):843–9.PubMedCrossRefGoogle Scholar
  30. 30.
    Xian J, Xu X, Wang Z, et al. MR imaging findings of the uveal schwannoma. AJNR Am J Neuroradiol. 2009;30(4):769–73.PubMedCrossRefGoogle Scholar
  31. 31.
    Pineda R 2nd, Urban RC Jr, Bellows AR, et al. Ciliary body neurilemmona. Unusual clinical findings intimating the diagnosis. Ophthalmology. 1995;102(6):918–23.PubMedCrossRefGoogle Scholar
  32. 32.
    Turell ME, Hayden BC, McMahon JT, et al. Uveal schwannoma surgery. Ophthalmology. 2009;116(1):163–e6.PubMedCrossRefGoogle Scholar
  33. 33.
    Kuchle M, Holbach L, Schlotzer-Schrehardt U, et al. Schwannoma of the ciliary body treated by block excision. Br J Ophthalmol. 1994;78(5):397–400.PubMedPubMedCentralCrossRefGoogle Scholar
  34. 34.
    Goto H, Mori H, Shirato S, et al. Ciliary body schwannoma successfully treated by local resection. Jpn J Ophthalmol. 2006;50(6):543–6.PubMedCrossRefGoogle Scholar
  35. 35.
    Cho YJ, Won JB, Byeon SH, et al. A choroidal schwannoma confirmed by surgical excision. Korean J Ophthalmol. 2009;23(1):49–52.PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Victoria M. L. Cohen
    • 1
  • Bertil E. Damato
    • 2
  • Arun D. Singh
    • 3
    Email author
  1. 1.Department of Ocular OncologyMoorfields Eye HospitalLondonUK
  2. 2.Nuffield Department of Clinical Neurosciences, University of OxfordJohn Radcliffe HospitalOxfordUK
  3. 3.Department of Ophthalmic OncologyCole Eye Institute, Cleveland ClinicClevelandUSA

Personalised recommendations